PRESS RELEASE
FOR IMMEDIATE RELEASE
Homegrown DOC2US launches RTKis Rapid Test Kit Intelligent System for COVID-19
A cost-effective solution catalyses economic activities under the National Recovery Plan
Kuala Lumpur, 26 July - DOC2US, the first telemedicine provider in Malaysia in compliance with the Ministry of Health to provide digitally signed e-prescription services, today announced the launch of its proprietary system to test, record, manage and report COVID-19 cases for corporates and the public. The system provides a cost-effective, credible and convenient means to comply with guidelines set by the Ministry of International Trade & Industry for economic sectors allowed to operate under Phase 2 of the National Recovery Plan.
RTKis (pronounces as Ar-Tee-kis) is a comprehensive solution consists of a Medical Device Authority (MDA) approved home-use RTK antigen test kit that allows user to conduct COVID-19 self-testing at home with their identity verification and test process validation as well as test result validation using artificial intelligent (AI) on the DOC2US RTKis platform. Positive result will then be uploaded to the Public Health Laboratory Information System (SIMKA) which is synchronized with the MySejahtera app.
Dr Raymond Choy, Chief Executive Officer of DOC2US said, “ The MITI guidelines require employees to be screened for COVID-19 twice prior to resumption of work and twice per week thereafter. With most businesses suffered loss of revenue due to the lockdowns, it is critical to provide a credible solution that is convenient and economical, thus enables allowed sectors to resume their activities while complying
with the MITI guidelines.”
While the Rapid Test Kit Intelligent System for COVID-19 RTKis comprises of the imperative component of a home testing kit that does not require the presence of a healthcare professional to administer, DOC2US deploys the use of AI to minimize fraud associated with any self-declaration.
Tan Aik-Keong, Director (Technology) of DOC2US and Chief Executive Officer of Agmo Studio Sdn Bhd, who developed the backend system said, “Our solution is comprehensive in design that it allows little to no room for fraud as users access the DOC2US RTKis platform via QR codes that is unique to each RTK antigen test kit sold under our package. Users will also need to verify their phone number, ID and validate their test process via photo taking and video recording. Our AI-powered system is using image classification engine with machine learning to identify the test result based on the uploaded test kit photo.”
Currently, the RTKis works with Gmate Saliva Antigen Test Kit imported exclusively by CityMedics, on this Dr Choy said, “We chose to kick start our RTKis with Gmate’s home test kit as it is credible with 91% sensitivity accredited by the Institute for Medical Research, Malaysia, non-invasive, so easy to use that users can perform the test in the safety of their homes, and no on-site doctor is needed to carry out the tests. Nevertheless, our system is designed to work with other test kits as well.”
DOC2US’ RTKis Rapid Test Kit Intelligent System for COVID-19 is sold at RM45 per package and is available via the DOC2US hotline 013-2862923.
Photos showing DOC2US RTKis User Interface
** END **
